Effect of the Benson Relaxation Technique on Clinical Outcomes of Oncology Patients Admitted to Intensive Care Units
1 other identifier
interventional
60
1 country
1
Brief Summary
The benson Relaxation Technique (BRT), developed by Dr. Herbert Benson, is a method aimed at reducing stress and anxiety through a series of simple steps designed to elicit the "Relaxation Response." This response is a physiological state that counteracts the harmful effects of stress, characterized by decreased heart rate, lower metabolism, and reduced breathing rate
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedAugust 6, 2025
June 1, 2024
9 months
October 19, 2024
August 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Heart rate
measure heart rate per min
daily for three days
Blood pressure
measure blood pressure in mmHg
daily for three days
Respiratory rate
measure respiratory rate per min
daily for three days
The Rhodes Index of Nausea, Vomiting, and Retching
It is a self-report tool designed to assess the severity and impact of nausea, vomiting, and retching on patients' 5-point categorical scales, the interval of each category was (maximum possible score/4-1 ) with the score being zero in the "none" category. For example, if the maximum possible score was 32, then, none: 0, mild: 1-8, moderate: 9-16, severe: 17-24, great: 24-32.
daily for three days
The Numeric Pain Rating Scale
The patient is asked to make three pain ratings, corresponding to current, best and worst pain experienced over the past 24 hours. scale is the most widely used single-dimension assessment scale.The total score is divided into 4 main categories: zero, which indicates no pain; 1-3 grades, which indicates mild pain; 4-6 grades, which indicate moderate pain; and 7-10 grades, which indicate severe pain
daily for three days
Insomnia Severity Index Scale
The Insomnia Severity Index (ISI) is a widely used self-report questionnaire designed to assess the severity of insomnia. It consists of seven questions, each rated on a scale that reflects the severity of sleep problems experienced over the last two weeks. The total score is calculated by summing the responses to all seven items, with potential scores ranging from 0 to 28. Total Score Calculation 0-7: No clinically significant insomnia 8-14: Subthreshold insomnia 15-21: Clinical insomnia (moderate severity) 22-28: Clinical insomnia (severe)
daily for three days
Secondary Outcomes (1)
Icu length
an average three months
Study Arms (2)
The benson group
EXPERIMENTALPatients who received the intervention
Control group
PLACEBO COMPARATORPatients who receive routine care in units
Interventions
The benson relaxation consisted of the following steps: (1) Sitting or lying down quietly in a comfortable position; (2) Closing eyes; (3) Deeply relaxing all muscles, beginning at the feet and progressing up to the face. Keeping them relaxed; (4) Breathing through the nose. (5) Maintaining a passive attitude and permitting relaxation to occur at its own pace; (6) Continuing for 15 minutes. When finished, sit quietly for several minutes, at first with eyes closed and later with eyes opened. Do not stand up for a few minutes. According to the agreement, the patients in both groups were required to perform the Benson relaxation technique regularly twice daily (morning and evening) for seven days in a row. Each session lasted 15 minutes
The routine care include in the unit will be delivered to control group
Eligibility Criteria
You may qualify if:
- Adult patients aged 18-60 years
- diagnosed with cancer
- alert and able to communicate.
You may not qualify if:
- Patients who refused to participate in the study
- Patients with cognitive impairment
- Patient who unable to communicate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Nursing
Damanhūr, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The studied patients will be masked for the intervention
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2024
First Posted
October 28, 2024
Study Start
November 1, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
August 6, 2025
Record last verified: 2024-06